Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) YoY EPS Growth : -55.88% (As of Sep. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Qinghai Spring Medicinal Resources Technology Co YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Qinghai Spring Medicinal Resources Technology Co's YoY EPS Growth for the quarter that ended in Sep. 2024 was -55.88%.

Qinghai Spring Medicinal Resources Technology Co's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was ¥-0.05.

Qinghai Spring Medicinal Resources Technology Co YoY EPS Growth Historical Data

The historical data trend for Qinghai Spring Medicinal Resources Technology Co's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qinghai Spring Medicinal Resources Technology Co YoY EPS Growth Chart

Qinghai Spring Medicinal Resources Technology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EPS Growth

Get a 7-Day Free Trial

-91.67

-5,500.00

22.22

-16.67

6.12

Qinghai Spring Medicinal Resources Technology Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
YoY EPS Growth	Get a 7-Day Free Trial															24.44	6.08	6.12	-51.35	-55.88

Qinghai Spring Medicinal Resources Technology Co YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Qinghai Spring Medicinal Resources Technology Co's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EPS Growth (A: Dec. 2023 )
=	(Earnings per Share (Diluted) (A: Dec. 2023 )	-	Earnings per Share (Diluted) (A: Dec. 2022 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2022 ) \|
=	(-0.46	-	-0.49)	/	\| -0.49 \|
=	6.12 %

Qinghai Spring Medicinal Resources Technology Co's YoY EPS Growth for the quarter that ended in Sep. 2024 is calculated as:

	YoY EPS Growth (Q: Sep. 2024 )
=	(Earnings per Share (Diluted) (Q: Sep. 2024 )	-	Earnings per Share (Diluted) (Q: Sep. 2023 ))	/	\| Earnings per Share (Diluted) (Q: Sep. 2023 )) \|
=	(-0.053	-	-0.034)	/	\| -0.034 \|
=	-55.88 %

Qinghai Spring Medicinal Resources Technology Co YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Qinghai Spring Medicinal Resources Technology Co's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Qinghai Spring Medicinal Resources Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qinghai Spring Medicinal Resources Technology Co Ltd (SHSE:600381) » Definitions » YoY EPS Growth

Traded in Other Exchanges

N/A

Address

East New Road 1, Xining Economic and Technological Development Zone, Xining, CHN, 810007

Website

http://www.verygrass.com

Qinghai Spring Medicinal Resources Technology Co Ltd is a China-based company that principally engaged in the integrated development, utilization, production, sales, and consulting services of the natural advantageous resources on the Qinghai-Tibet plateau, as well as the development and utilization of other biological resources. The Company's main products are the cordyceps sinensis series products under the Verygrass brand, which includes cordyceps sinensis pure powder tablet, processed cordyceps sinensis, and raw cordyceps sinensis.

Executives

Xiao Rong	Director
Lu Yi Ping	Director

Qinghai Spring Medicinal Resources Technology Co Headlines

No Headlines